Oculis Holding Ag (OCSAW) SEC Filings — 2024

Filings

• Oculis Holding Ag SC 13G Filing — SC 13G · Dec 9, 2024
• Oculis Holding AG Discloses Insider Transactions — 6-K · Nov 29, 2024
• Oculis Holding Ag SC 13G/A Filing — SC 13G/A · Nov 7, 2024
• Oculis Holding AG Reports Q3 2024 Unaudited Results — 6-K · Nov 7, 2024
• Oculis Holding AG Files 6-K with Q2 2024 Financials — 6-K · Aug 27, 2024
• Oculis Holding AG Announces Positive Phase 2b Trial Results — 6-K · Jun 10, 2024
• Oculis Holding AG Announces AGM Results and New Financing — 6-K · May 31, 2024
• Oculis Holding AG Q1 2024 Results Announced — 6-K · May 8, 2024
• Oculis Holding AG Announces 2024 AGM Details — 6-K · Apr 29, 2024
• Oculis Raises $58.75M, Lists on Nasdaq Iceland — 6-K · Apr 22, 2024
• Oculis Holding AG Announces Registered Direct Offering — 6-K · Apr 11, 2024
• Oculis Holding AG Reports 2023 Financial Results — 6-K · Mar 19, 2024
• Oculis Holds R&D Day, Updates Clinical Programs & Leadership — 6-K · Feb 28, 2024
• Oculis Holding Ag SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Pivotal bioVenture Partners Lowers Oculis Stake to 5.0% — SC 13G/A · Feb 12, 2024
• LSP 7 Coöperatieve U.A. Reports Passive Stake in Oculis Holding AG — SC 13G · Feb 9, 2024